CBIZ (NYSE:CBZ) experienced a significant share price surge, reaching approximately $55 in premarket trading on Wednesday, following the announcement of a $5 billion acquisition proposal from Grant Thornton Advisors. The stock was quoted at $54.45, just 1.0% below the $55 per share cash offer, indicating a tight arbitrage spread that reflects strong investor confidence in the deal's completion.
The acquisition values CBIZ at an enterprise value of $5 billion, though the basic common equity is estimated at around $2.99 billion based on 54.27 million shares outstanding. This leaves a preliminary enterprise-value bridge of approximately $2.01 billion, representing about 40% of the disclosed value. The bridge accounts for net debt and other valuation adjustments, highlighting the difference between the headline figure and the actual equity payout to shareholders.
CBIZ's adjusted EBITDA declined by 14.3% in the second quarter to $103 million, while net income fell 55.6% to $19 million. Revenue edged down 0.2% to $682 million. Net leverage stood at 3.4 times, a slight decrease from the previous year. The company retracted its 2026 outlook and canceled its scheduled earnings call, citing the transaction as the reason. CBIZ continues to integrate Marcum, which it acquired in 2024 for $2.3 billion.
The bid premium of 17.8% above Tuesday's closing price of $46.70 represents a roughly 54% increase compared to the 30-day volume-weighted average price. However, the $55 offer is still 38% below CBIZ's $88.65 high from early 2025. The premium comes after a sustained decline in the share price, reflecting the challenging operating environment.
Grant Thornton is expected to become the fifth-largest professional-services firm in the U.S. post-merger, with domestic annual revenue projected to exceed $5 billion and global platform revenue approaching $7.5 billion. Jim Peko, CEO of Grant Thornton, stated that the merger would "broaden our ability to support businesses through every stage of growth."
Post-completion, New Mountain Capital plans to spin off CBIZ's Benefits and Insurance Services division as an independent entity. Total financing commitments amount to $5.2 billion, covering deal expenses. The buyer would pay a $198.4 million termination fee under certain conditions, representing roughly 6.6% of the preliminary basic equity commitment. CBIZ's standard breakup fee is $107.5 million, reducing to $49.6 million for go-shop deals meeting specific criteria.
CBIZ is permitted to solicit other offers until August 27, which currently represents the primary opportunity for a price exceeding $55. Grant Thornton anticipates closing the deal in the fourth quarter. Risks include shareholder approval and U.S. antitrust clearance, with an outside date of July 28, 2027. Should the transaction fail, CBIZ could face renewed risks related to margin pressure, leverage, and Marcum integration.
In recent premarket trading, buyers were offering close to the full value, shifting focus from independent earnings to the deal's completion probability and the possibility of an increased offer. The tight spread suggests traders are assigning strong odds of a close, though the absence of a competing bid limits potential gains.
